Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Emergency urinary drainage followed by PCNL in obstructive urosepsis

Official title: Effect of Emergency Urinary Drainage Method on Subsequent Percutaneous Nephrolithotomy Outcomes in Patients With Obstructive Urosepsis: A Prospective Comparative Study

Run by Beni-Suef University · NCT07826325 · Data updated 2026-11-12

Doctors test whether the method of emergency drainage (retrograde ureteral stent or percutaneous nephrostomy) affects how well patients do after undergoing definitive PCNL.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorBeni-Suef University
Academic / other
Locations1 site (Banī Suwayf, Beni Suweif Governorate)
StatusRecruiting
StartedOctober 2026
Main results expectedApril 2028
Study endsJune 2028
Registry record updatedSeptember 17, 2026
Trial IDNCT07826325 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with obstructive renal or proximal ureteral stones presenting with urosepsis who require emergency drainage and are scheduled for PCNL after infection control.

Probably not a fit

Patients who do not undergo PCNL after drainage or who have non-obstructive stones are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective study compares outcomes of patients with obstructive urosepsis who receive emergency urinary decompression either by retrograde ureteral stent or by percutaneous nephrostomy, followed by definitive percutaneous nephrolithotomy after infection resolves. Key outcomes include stone-free rate, operative time, blood loss, postoperative complications, hospital stay, and need for additional procedures. All participants have confirmed infection control and will undergo PCNL under general anesthesia, with data collected on surgical parameters and complication grading. Stone-free status will be assessed 2-4 weeks after surgery using NCCT or ultrasound. The study is conducted at Beni-Suef University and aims to inform optimal sequencing and drainage strategy in this high-risk scenario.

Why it matters

Potential benefit: If successful, the study could guide choice of emergency drainage to improve PCNL outcomes and reduce complications.

How similar studies have gone: Previous work supports feasibility of emergency drainage approaches, but direct comparison to subsequent PCNL outcomes in this setting is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older.
* Presence of renal or proximal ureteral stones.
* Presentation with urosepsis secondary to obstructive urolithiasis.
* Emergency urinary decompression performed by either retrograde ureteral stent (Double-J stent) or percutaneous nephrostomy (PCN).
* Patients scheduled for definitive stone management via percutaneous nephrolithotomy (PCNL) after clinical stabilization and infection resolution.
* Written informed consent obtained prior to enrollment.

Exclusion Criteria:

* Congenital renal anomalies (e.g., horseshoe kidney, ectopic kidney).
* Pregnancy.
* Uncorrectable coagulopathy or bleeding disorders.
* Active, uncontrolled urinary tract infection at the time of definitive PCNL.
* Severe cardiopulmonary comorbidities rendering the patient unfit for surgery or general anesthesia.
* Patients managed definitively by other modalities (e.g., ureteroscopy or ESWL alone).

Where it's running

  • Faculty of Medicine, Beni-Suef University
    Banī Suwayf, Beni Suweif Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.